Pfizer Seeks FDA Emergency Approval for COVID Vaccine in Younger Kids
THURSDAY, Oct. 7, 2021 (HealthDay News) — Pfizer Inc. announced Thursday that it has asked the U.S. Food and Drug Administration for emergency approval for its coronavirus vaccine to be given to children between the ages of 5 and 11. “We’re committed to working with the FDA with the ultimateContinue Reading